Aging is a progressive process with degenerative changes of various tissues and organs. As a classic model organism in genetics and neurobiology, Caenorhabditis elegans is also a powerful system in aging and behavioral studies and can be used at both the molecular and organismal levels to evaluate potential therapeutics for age-related neurodegeneration, owing to its short life span, relative simplicity, and high degree of experimental tractability as well as significant conservation of disease genes and signaling pathways with humans. We attempt here to summarize the use of C. elegans models in exploring traditional Chinese medicine for potential remedies against aging and neurodegeneration.
Get full access to this article
View all access options for this article.
References
1.
BlagosklonnyMV. Prospective treatment of age-related diseases by slowing down aging. Am J Pathol, 2012; 181:1142–1146.
2.
SluderAE, BaumeisterR. From genes to drugs: Target validation in Caenorhabditis elegans. Drug Discov Today Technol, 2004; 1:171–177.
3.
SwierczekNA, GilesAC, RankinCH, KerrRA. High-throughput behavioral analysis in C. elegans. Nat Methods, 2011; 8:592–598.
4.
ShoyamaT, ShimizuY, SudaH. Decline in oxygen consumption correlates with lifespan in long-lived and short-lived mutants of Caenorhabditis elegans. Exp Gerontol, 2009; 44:784–791.
5.
ZhangH, PanN, XiongS, ZouS, LiH, XiaoL, CaoZ, TunnacliffeA, HuangZ. Inhibition of polyglutamine-mediated proteotoxicity by Astragalus membranaceus polysaccharide through the DAF-16/FOXO transcription factor in Caenorhabditis elegans. Biochem J, 2012; 441:417–424.
6.
YangX, ZhangP, WuJ, XiongS, JinN, HuangZ. The neuroprotective and lifespan-extension activities of Damnacanthus officinarum extracts in Caenorhabditis elegans. J Ethnopharmacol, 2012; 141:41–47.
7.
LiH, XuJ, LiuY, AiS, QinF, LiZ, ZhangH, HuangZ. Antioxidant and moisture-retention activities of the polysaccharide from Nostoc commune. Carbohydr Polym, 2011; 83:1821–1827.
8.
GidalevitzT, Ben-ZviA, HoKH, BrignullHR, MorimotoRI. Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science, 2006; 311:1471–1474.
9.
LiuJ, ZhangB, LeiH, FengZ, LiuJ, HsuAL, XuXZ. Functional aging in the nervous system contributes to age-dependent motor activity decline in C. elegans. Cell Metab, 2013; 18:392–402.
10.
DosanjhLE, BrownMK, RaoG, LinkCD, LuoY. Behavioral phenotyping of a transgenic Caenorhabditis elegans expressing neuronal amyloid-beta. J Alzheimers Dis, 2010; 19:681–690.
11.
XinL, YamujalaR, WangY, WangH, WuWH, LawtonMA, LongC, DiR. Acetylcholineestarase-inhibiting alkaloids from Lycoris radiata delay paralysis of amyloid beta-expressing transgenic C. elegans CL4176. PLoS One, 2013; 8:e63874.
12.
WuY, WuZ, ButkoP, ChristenY, LambertMP, KleinWL, LinkCD, LuoY. Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J Neurosci, 2006; 26:13102–13113.
13.
HilliardMA, ApicellaAJ, KerrR, SuzukiH, BazzicalupoP, SchaferWR. In vivo imaging of C. elegans ASH neurons: Cellular response and adaptation to chemical repellents. EMBO J, 2005; 24:63–72.
14.
KunitomoH, SatoH, IwataR, SatohY, OhnoH, YamadaK, IinoY. Concentration memory-dependent synaptic plasticity of a taste circuit regulates salt concentration chemotaxis in Caenorhabditis elegans. Nat Commun, 2013; 4:2210.
15.
BraungartE, GerlachM, RiedererP, BaumeisterR, HoenerMC. Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings. Neurodegener Dis, 2004; 1:175–183.
16.
RamotD, JohnsonBE, BerryTLJr, CarnellL, GoodmanMB. The Parallel Worm Tracker: A platform for measuring average speed and drug-induced paralysis in nematodes. PLoS One, 2008; 3:e2208.
17.
QiaoL, LuoS, LiuY, LiX, WangG, HuangZ. Reproductive and locomotory capacities of Caenorhabditis elegans were not affected by simulated variable gravities and spaceflight during the Shenzhou-8 mission. Astrobiology, 2013; 13:617–625.
